ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Regarding the Addition of CDK4/6 Inhibitor to Postoperative Endocrine Therapy in Patients With HR-Positive HER2-Negative High-Risk Breast Cancer.

Kazuki Hashimoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.